Persistent Asthma
📧 Sign up to get email alerts when something new happens for Persistent Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: Cockroach Immunotherapy in Children and Adolescents [Phase 2]
Phase 2 trial update for cockroach immunotherapy in children/adolescents with persistent asthma; trial completed with results posted in 2023…
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: The Possible Efficacy and Safety of L-carnitine and Biotin as Adjunctive Therapies in Children With Moderate Persistent Asthma [Phase 3]
A Phase 3 clinical trial evaluating L-carnitine and biotin as adjunctive therapies in children with moderate persistent asthma; the study st…
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI) [Phase 2]
Phase 2 dose–response trial of Beclometasone Dipropionate/Formoterol pMDI in mild persistent asthma completed.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of QAW039 [Phase 2]
Phase 2 trial update reporting efficacy, safety, and pharmacokinetics of QAW039 in persistent asthma.
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma [Phase 3]
Phase 3 pharmacodynamic bioequivalence study of metered dose inhalers containing albuterol sulfate in patients with stable mild asthma; tria…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2020-07-07Clinical Trial Update: Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients [Phase 4]
A Phase 4 trial comparing fluticasone/formoterol K-haler medium strength to an ICS/LABA high-strength regimen in persistent asthma was withd…
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years. [Phase 2]
Phase 2 trial comparing systemic safety of Flutiform pMDI, Fluticasone pMDI, and Beclometasone Autohaler in children aged 5 to <12 with mild…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children. [NA]
A clinical trial update evaluating the effect of 2 weeks of montelukast treatment on FeNO, small airway dysfunction, and lung heterogeneity …
-
CLINICAL_TRIALS trial_result · 2017-12-11Clinical Trial Update: A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma [Phase 3]
Phase 3 trial assessing safety and efficacy of beclomethasone dipropionate delivered via breath-actuated inhaler in patients aged 12 and old…
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma [Phase 3]
Phase 3 trial assessing efficacy and safety of beclomethasone dipropionate in adolescents and adults (12+) with persistent asthma has comple…
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma [Phase 3]
Phase 3 long-term safety study of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI in patients with persistent asthma …
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma
This document reports the completion of a clinical trial evaluating the frequency of activity limitation in patients with persistent asthma.
-
CLINICAL_TRIALS withdrawal · 2012-08-24Clinical Trial Update: A National Program for Severe Asthma: The Canadian Severe Asthma Network
A national program trial for severe asthma (Canadian Severe Asthma Network) has been withdrawn from the ClinicalTrials.gov registry.